Accelerates drug discovery by applying advanced machine learning to biological data for predictive therapeutic development.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Xaira Therapeutics is a biotechnology company advancing artificial intelligence‑driven drug discovery and development to transform how new therapies are identified, designed, and progressed from concept toward clinical use. It builds integrated AI and biological data platforms that enhance understanding of complex biology and streamline the creation of innovative medicines with predictive insights and scalable computational methods. The organization aims to modernize the entire therapeutic discovery process through cutting‑edge machine learning research and data‑centric discovery approaches.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Xaira Management Team
Xaira Valuations & Financials
View real-time NPM data on Xaira stock including daily Xaira stock price estimates, valuation history, and historical share price information. Access Xaira financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Xaira pricing across six independent market signals. Looking for private company due diligence data sources on Xaira? Get in touch to learn more.
Similar Companies
like Xaira
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Silverfort
Cybersecurity
Unified identity protection, providing security solutions for both on-premises and cloud environments.
Carallel
Healthcare & Life Sciences
Develops a support platform that guides caregivers with resources, expert assistance, and tools for managing care responsibilities.
Nouscom
Develops innovative cancer immunotherapies and vaccines using viral vector technology to target multiple tumor antigens and boost immune response
Instabase
AI & Machine Learning
Cloud-based platform for interactive data applications.
Prime Intellect
AI & Machine Learning
Connects global compute infrastructure and AI training tools to empower collaborative model development and deployment.
ICE Thermal Harvesting
Develops technology to capture and reuse industrial waste heat, improving energy efficiency and reducing costs.
GrubMarket
Consumer
Application for consumers to order fresh, locally-sourced food through their mobile and web apps.
Experic
Healthcare & Life Sciences
Supports drug development, manufacturing, and clinical supply logistics for life science companies.
FAQ
We have answers
Xaira stock does not trade on public stock exchanges. Xaira stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Xaira stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Xaira Stock does not trade on public stock exchanges. In order to sell Xaira shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Xaira does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Xaira share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Xaira stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Xaira stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Xaira stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Xaira is a private company and has not had an IPO. There is currently no Xaira IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Xaira IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
